Drug intelligence / Profile preview

progesterone

Development stage
Approved
Lead developer
Mochida Pharmaceutical
Modality
Small Molecules
Administration
Oral, Intramuscular, Vaginal, Topical, Subcutaneous, Rectal
01

Overview

Progesterone is a naturally occurring steroid hormone and the principal progestogen in humans. It plays a central role in regulating the menstrual cycle, supporting pregnancy, and embryogenesis. Medically, progesterone is used for hormone replacement therapy (HRT) in postmenopausal women (typically combined with estrogen to prevent endometrial hyperplasia), to induce menstruation in women with amenorrhea due to progesterone deficiency, as part of fertility treatments including support of early pregnancy and prevention of miscarriage, and for contraception. Its mechanism involves binding as an agonist to nuclear progesterone receptors (nPRs) and membrane progesterone receptors (mPRs), modulating gene expression that maintains the endometrium for implantation or suppresses ovulation depending on context. Progesterone also acts as an antagonist at mineralocorticoid receptors, partial agonist at glucocorticoid receptors (with low potency), antagonist at sigma σ1 receptor, negative allosteric modulator of nicotinic acetylcholine receptors, and ligand for PGRMC1. Pharmaceutical formulations are chemically identical to endogenous human ovarian progesterone but are typically synthesized from plant sources[2][3][5].

Brand names
PrometriumCrinoneEndometrinProchieveBijuva
Other names
pregn-4-ene-3,20-dione
02

Targets

SIGMAR1 (Sigma non-opioid intracellular receptor 1)MR (Mineralocorticoid receptor)GR (Glucocorticoid receptor)mPR (Membrane progesterone receptors)PR (Progesterone receptor)

Beyond the preview

Go deeper on progesterone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on progesterone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call